Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Adenosine Receptor
    (1)
  • Apoptosis
    (1)
  • GABA Receptor
    (1)
  • Glucocorticoid Receptor
    (1)
  • PDE
    (1)
  • Parasite
    (1)
  • Reactive Oxygen Species
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

16hbe

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Activity
  • Natural Products
    1
    TargetMol | inventory
Emamectin Benzoate
T15212155569-91-8
Emamectin Benzoate (MK-244), by binding gamma-aminobutyric acid (GABA) receptor and glutamate-gated chloride channels disrupting nerve signals within arthropods, acts as a chloride channel activator.
  • $29
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Doxofylline
T048069975-86-6
Doxofylline (Doxophylline) is a methylxanthine derivative with the presence of a dioxolane group in position 7. As a drug used in the treatment of asthma, doxofylline has shown similar efficacy to theophylline but with significantly fewer side effects in animal and human studies.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Beclometasone dipropionate
T11275534-09-8
Beclometasone dipropionate (Vancenase) is the dipropionate ester of a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. After cell surface receptor attachment and cell entry, beclomethasone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.
  • $31
In Stock
Size
QTY
N-3-oxo-dodecanoyl-L-Homoserine lactone
T21633168982-69-2
N-3-oxo-dodecanoyl-L-Homoserine lactone (3-oxo-C12-HSL), a quorum-sensing signaling molecule synthesized by P. aeruginosa and specific B. cepacia complex strains [1][2], facilitates bacterial gene expression modulation in response to cell density escalation and triggers IL-8 production in 16HBE human bronchial epithelial cells [3].
    6-8 weeks
    Inquiry